Microbial factors in spondyloarthropathies: Insights from population studies

Current Opinion in Rheumatology

Volumn 15, Issue 4, 2003, Pages 408-412

  Leirisalo Repo, Marjatta ^a   Hannu, Timo ^a   Mattila, Leena ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

HLA B27; Infection; Reactive arthritis; Spondyloarthropathy

Indexed keywords

BACTERIAL ANTIGEN; BCG VACCINE; CIPROFLOXACIN; ERYTHROMYCIN; HLA B27 ANTIGEN; LYMECYCLINE; PENICILLIN DERIVATIVE; TETRACYCLINE;

CAMPYLOBACTER JEJUNI; CHEMOTHERAPY; DISEASE SEVERITY; EPIDEMIC; GRAM NEGATIVE INFECTION; HUMAN; IRIDOCYCLITIS; MICROORGANISM; NONHUMAN; PATHOGENESIS; POPULATION RESEARCH; PRIORITY JOURNAL; REACTIVE ARTHRITIS; RECURRENT DISEASE; REVIEW; SALMONELLOSIS; SHIGELLA; SHIGELLA FLEXNERI; SHIGELLA SONNEI; SPONDYLOARTHROPATHY; URETHRITIS; UTERINE CERVICITIS; YERSINIA; YERSINIA ENTEROCOLITICA;

ARTHRITIS, REACTIVE; BACTERIAL INFECTIONS; FINLAND; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; POPULATION SURVEILLANCE; SPONDYLITIS, ANKYLOSING;

EID: 0038434106     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200307000-00006     Document Type: Review

References (66)

1. Dougados M, van der LS, Juhlin R, et al.: The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum 1991, 34:1218-1227.
2. Lauhio A, Leirisalo-Repo M, Lahdevirta J, et al.: Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum 1991, 34:6-14.
3. Mazumder RN, Salam MA, Ali M, et al.: Reactive arthritis associated with Shigella dysenteriae type 1 infection. J Diarrhoeal Dis Res 1997, 15:21-24.
4. Goudswaard J, Sabbe L, Te WW: Reactive arthritis as a complication of Campylobacter lari enteritis. J Infect 1995, 31:171.
5. Gran JT, Hjetland R, Andreassen AH: Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae. Scand J Rheumatol 1993, 22:43-44.
6. Braun J, Laitko S, Treharne J, et al.: Chlamydia pneumoniae-a new causative agent of reactive arthritis and undifferentiated oligoarthritis. Ann Rheum Dis 1994, 53:100-105.
7. Saario R, Toivanen A: Chlamydia pneumoniae as a cause of reactive arthritis. Br J Rheumatol 1993, 32:1112.
8. Beaudreuil J, Hayem G, Meyer O, et al.: Reactive arthritis ascribed to Chlamydia pneumoniae: report of a case. Rev Rhum Engl Ed 1995, 62:224.
9. Hannu T, Puolakkainen M, Leirisalo-Repo M: Chlamydia pneumoniae as a triggering infection in reactive arthritis. Rheumatology (Oxf) 1999, 38:411-414.
10. Hannonen P, Hakola M, Mottonen T, et al.: Reactive oligoarthritis associated with Clostridium difficile colitis. Scand J Rheumatol 1989, 18:57-60.
11. Putterman C, Rubinow A: Reactive arthritis associated with Clostridium difficile pseudomembranous colitis. Semin Arthritis Rheum 1993, 22:420-426.
12. Keating RM, Vyas AS: Reactive arthritis following Clostridium difficile colitis. West J Med 1995, 162:61-63.
13. Schwartzenberg JM, Smith DD, Lindsley HB: Bacillus Calmette-Guerin associated arthropathy mimicking undifferentiated spondyloarthropathy. J Rheumatol 1999, 26:933-935.
14. Mas AJ, Romera M, Valverde Garcia JM: Articular manifestations after the administration of intravesical BCG. Joint Bone Spine 2002, 69:92-93.
15. Peng SL: Rheumatic manifestations of parasitic diseases. Semin Arthritis Rheum 2002, 31:228-247. A good and extensive review with a description of the clinical spectrum of parasitic rheumatism.
16. Leirisalo-Repo M: Therapeutic aspects of spondyloarthropathies-a review. Scand J Rheumatol 1998, 27:323-328.
17. Wilkinson NZ, Kingsley GH, Jones HW, et al.: The detection of DNA from a range of bacterial species in the joints of patients with a variety of arthritides using a nested, broad-range polymerase chain reaction. Rheumatology (Oxf) 1999, 38:260-266.
18. Schumacher HR Jr, Arayssi T, Crane M, et al.: Chlamydia trachomatis nucleic acids can be found in the synovium of some asymptomatic subjects. Arthritis Rheum 1999, 42:1281-1284.
19. Pacheco-Tena C, Alvarado DLB, Lopez-Vidal Y, et al.: Bacterial DNA in synovial fluid cells of patients with juvenile onset spondyloarthropathies. Rheumatology (Oxf) 2001, 40:920-927.
20. Weyand CM, Goronzy JJ: Clinically silent infections in patients with oligoarthritis: results of a prospective study. Ann Rheum Dis 1992, 51:253-258.
21. Aggarwal A, Misra R, Chandrasekhar S, et al.: Is undifferentiated seronegative spondyloarthropathy a forme fruste of reactive arthritis? Br J Rheumatol 1997, 36:1001-1004.
22. Fendler C, Laitko S, Sorensen H, et al.: Frequency of triggering bacteria in patients with reactive arthritis and undifferentiated oligoarthritis and the relative importance of the tests used for diagnosis. Ann Rheum Dis 2001, 60:337-343.
23. Granfors K, Jatkanen S, von Essen R, et al.: Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med 1989, 320:216-221.
24. Ebringer A: Ankylosing spondylitis is caused by Klebsiella: evidence from immunogenetic, microbiologic, and serologic studies. Rheum Dis Clin North Am 1992, 18:105-121.
25. Russell AS, Suarez Almazor ME: Ankylosing spondylitis is not caused by Klebsiella. Rheum Dis Clin North Am 1992, 18:95-104.
26. Husby G, Tsuchiya N, Schwimmbeck PL, et al.: Cross-reactive epitope with Klebsiella pneumoniae nitrogenase in articular tissue of HLA-B27+ patients with ankylosing spondylitis. Arthritis Rheum 1989, 32:437-445.
27. Hülsemann JL, Zeidler H: Undifferentiated arthritis in an early synovitis outpatient clinic. Clin Exp Rheumatol 1995, 13:37-43.
28. Isomäki H, Raunio J, von Essen R, et al.: Incidence of inflammatory rheumatic diseases in Finland. Scand J Rheumatol 1978, 7:188-192.
29. Leirisalo M, Skylv G, Kousa M, et al.: Followup study on patients with Reiter's disease and reactive arthritis, with special reference to HLA-B27. Arthritis Rheum 1982, 25:249-259.
30. Valtonen VV, Leirisalo M, Pentikäinen PJ, et al.: Triggering infections in reactive arthritis. Ann Rheum Dis 1985, 44:399-405.
31. Bengtsson A, Ahlstrand C, Lindström FD, et al.: Bacteriological findings in 25 patients with Reiter's syndrome (reactive arthritis). Scand J Rheumatol 1983, 12:157-160.
32. Locht H, Molbak K, Krogfelt KA: High frequency of reactive joint symptoms after an outbreak of Salmonella enteritidis. J Rheumatol 2002, 29:767-771. An interesting description of joint symptoms in association with Salmonella infection during an outbreak.
33. Sieper J, Braun J, Wu P, et al.: The possible role of Shigella in sporadic enteric reactive arthritis. Br J Rheumatol 1993, 32:582-585.
34. Huhtinen M, Karma A: HLA-B27 typing in the categorisation of uveitis in a HLA-B27 rich population. Br J Ophthalmol 2000, 84:413-416.
35. Huhtinen M, Laasila K, Granfors K, et al.: Infectious background of patients with a history of acute anterior uveitis. Ann Rheum Dis 2002, 61:1012-1016. A new approach to search for triggering factors to acute and recurrent anterior uveitis. Patients with several AAU in their history have serologic scars more often than those with less frequent attacks.
36. Huhtinen M, Puolakkainen M, Laasila K, et al.: Chlamydial antibodies in patients with previous acute anterior uveitis. Invest Ophthalmol Vis Sci 2001, 42:1816-1819.
37. Kvien TK, Glennås A, Melby K, et al.: Reactive arthritis: incidence, triggering agents and clinical presentation. J Rheumatol 1994, 21:115-122.
38. Söderlin MK, Börjesson O, Kautiainen H, et al.: Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann Rheum Dis 2002, 61:911-915. A well-done epidemiologic survey of the incidence of early arthritis (duration ≥3 months) in a Swedish county. The incidence of reactive arthritis was 28 in 100,000.
39. Glennås A, Kvien TK, Melby K, et al.: Reactive arthritis: a favorable 2 year course and outcome, independent of triggering agent and HLA-B27. J Rheumatol 1994, 21:2274-2280.
40. Hannu T, Mattila L, Rautelin H, et al.: Campylobacter-triggered reactive arthritis: a population-based study. Rheumatology (Oxf) 2002, 41:312-318. An extensive study with population controls on the incidence and clinical presenration of reactive arthritis and associated symptoms in the Finnish population. Reactive arthritis occurred in 7% of the patients with positive stool culture, with the incidence of campyloarthritis four in 100,000. New information is included on disease characteristics.
41. Mattila L, Leirisalo-Repo M, Pelkonen P, et al.: Reactive arthritis following an outbreak of Salmonella bovismorbificans infection. J Infect 1998, 36:289-295.
42. Mattila L, Leirisato-Repo M, Koskimies S, et al.: Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol 1994, 33:1136-1141.
43. Locht H, Krogfelt KA: Comparison of rheumatological and gastrointestinal symptoms after infection with Campylobacter jejuni/coli and enterotoxigenic Escherichia coli. Ann Rheum Dis 2002, 61:448-452. An interesting study based on questionnaires on the occurrence of musculoskeletal symptoms in patients with stool culture-positive Campylobaoter infection, with an interesting control population of those with enterotoxic E. coli infection. The rate of musculoskeletal symptoms was high in Campylobacter infection (16%), but the control patients also had a surprisingly high frequency (6%).
44. Bardin T. Enel C, Cornelis F, et al.: Antibiotic treatment of venereal disease and Reiter's syndrome in a Greenland population. Arthritis Rheum 1992, 35:190-194.
45. Toivanen A, Yli-Kerttula T, Luukkainen R, et al.: Effect of antimicrobial treatment on chronic reactive arthritis. Clin Exp Rheumatol 1993, 11:301-307.
46. Sieper J, Fendler C, Laitko S, et al.: No benefit of long-term ciprefloxacin treatment in patients with reactive arthritis and undifferentiated oligoarthritis: a three-month, multicenter, double-blind, randomized, placebo-controlled study. Arthritis Rheum 1999, 42:1386-1396.
47. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, et al.: Effect of e three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis 2000, 59:565-570.
48. Hannu T, Mattila L, Siitonen A, et al.: Reactive arthritis following an outbreak of Salmonella typhimurium phage type 193 infection. Ann Rheum Dis 2002, 61:264-266. A description of a small outbreak with a Salmonella typhimurium of a rare phage type. The result may indicate that early use of antibiotics for the gut infection may prevent the development of musculoskeletal complications.
49. Berthelot JM, Glemarec J, Guillot P, et al.: New pathogenic hypotheses for spondyloarthropathies. Joint Bone Spine 2002, 69:114-122. An updated review of different pathogenic mechanisms suggested to play a role in the development of spondyloarthropathies.
50. McMichael A, Bowness P: HLA-B27: natural function and pathogenic role in spondyloarthritis. Arthritis Res 2002, 4(suppl 3):S153-S158. A well-written review on the function of HLA-B27 with respect to the immune consequences end pathogenicity.
51. Huhtinen M, Repo H, Laasila K, et al.: Systemic inflammation and innate immune response in patients with previous anterior uveitis. Br J Ophthalmol 2002, 86:412-417. New evidence for the role on innate immunity in the pathogenesis of spondyloarthropathies examined from the view of AAU.
52. Noer HR: An "experimental" epidemic of Reiter's syndrome. JAMA 1966, 198:693-698.
53. Simon DG, Kaslow RA, Rosenbaum J, et al.: Reiter's syndrome following epidemic shigellosis. J Rheumatol 1981, 8:969-973.
54. Eastmond CJ: Gram-negative bacteria and B27 disease. Br J Rheumatol 1983, 22:67-74.
55. Bremell T, Bjelle A, Svedhem A: Rheumatic symptoms following an outbreak of Campylobacter enteritis: a five year follow up. Ann Rheum Dis 1991, 50:934-938.
56. Lindholm H, Visakorpi R: Late complications after a Yersinia enterecolitica epidemic: a follow up study. Ann Rheum Dis 1991, 50:694-696.
57. Tertti R, Granfors K, Lehtonen OP, et al.: An outbreak of Yersinia pseudotuberculosis infection. J Infect Dis 1984, 149:245-250.
58. Tertti R, Vuento R, Mikkola P, et al.: Clinical manifestations of Yersinia pseudotuberculosis infection in children. Eur J Clin Miorobiol Infect Dis 1989, 8:587-591.
59. Håkansson U, Eitrem R, Low B, et al.: HLA-antigen b27 in cases with joint affections in an outbreak of salmonellosis. Scand J Infect Dis 1976, 8:245-248.
60. Inman RD, Johnston ME, Hodge M, et al.: Postdysenteric reactive arthritis: a clinical and immunogenetic study following an outbreak of salmonellosis. Arthritis Rheum 1988, 31:1377-1383.
61. Thomson GT, Chiu B, De Rubeis D, et al.: Immunoepidemiology of post-Salmonella reactive arthritis in a cohort of women. Clin Immunol Immunopathol 1992, 64:227-232.
62. Locht H, Kihlström E, Lindström FD: Reactive arthritis after Salmonella among medical doctors-study of an outbreak. J Rheumatol 1993, 20:845-848.
63. Thomson GT, Alfa M, Orr K, et al.: Secretory immune response and clinical sequelae of Salmonella infection in a point source cohort. J Rheumatol 1994, 21:132-137.
64. Samuel MP, Zwillich SH, Thomson GT, et al.: Fast food arthritis-a clinico-pathologic study of post-Salmonella reactive arthritis. J Rheumatol 1995, 22:1947-1952.
65. Thomson GT, DeRubeis DA, Hodge MA, et al.: Post-Salmonella reactive arthritis: late clinical sequelae in a point source cohort. Am J Med 1995, 98:13-21.
66. McColl GJ, Diviney MB, Holdsworth RF, et al.: HLA-B27 expression and reactive arthritis susceptibility in two patient cohorts infected with Salmonella typhimurium. Aust N Z J Med 2000, 30:28-32.